Details

NameSymbolSector
BHARAT IMMUNOLOGICALS & BIOLOGICALSBIBCLPharmaceuticals
Open
17.52
High
18
Low
17.5
Close
17.64
Volume
33811
Exchange
bse
Time
28-Apr-2026

Outlook

Score:

2.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofBharatImmunologicals&Biologicalsis
None
EstimatedStoplossofBharatImmunologicals&Biologicalsis
17.5
BharatImmunologicals&Biologicalshasa
Bullishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofBharatImmunologicals&Biologicalsis
Unpredictableℹ
.

Trend

BharatImmunologicals&Biologicalsisin
Sideways trendℹ
.
PriceofBharatImmunologicals&Biologicalsis
Upℹ
by

2.56

%.
Target
Buy@

15.24

Sell@

19.9

Current@

17.64

Volume

ThetradevolumesofBharatImmunologicals&Biologicalshavebeen
Underperformingℹ
ThoughthevolumetrendforBharatImmunologicals&Biologicalsappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofBharatImmunologicals&Biologicalsis

Up

by

8.47

%

Valuation

ThecurrentmarketpriceofBharatImmunologicals&Biologicalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth185crandtotalassetsworth185cr,thebalancesheetofBharatImmunologicals&Biologicalsis:
Balancedℹ
.
Cashflow
BharatImmunologicals&Biologicalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 3cr

.Itis
Downℹ
by

200

%.
41.67% i.e. ₹ 10cr earned in operatingℹ
0% in investingℹ
58.33% i.e. ₹ 14cr spent in financingℹ
0% in otherℹ
BharatImmunologicals&Biologicalshas
Sufficientℹ
cashflowbecausethereis

Surplus

of

₹ 3cr

.Itis
Upℹ
by

0

%.
48.28% i.e. ₹ 42cr spent in operatingℹ
0% in investingℹ
51.72% i.e. ₹ 45cr earned in financingℹ
0% in otherℹ
Income
TheincomeofBharatImmunologicals&Biologicalsis

₹ 0cr

and

Loss

is:

₹ 4cr

BharatImmunologicals&BiologicalsLossesincreasedby:

0

%andIncomeisUpby:

0

%
TheincomeofBharatImmunologicals&Biologicalsis

₹ 0cr

and

Loss

is:

₹ 4cr

BharatImmunologicals&BiologicalsLossesincreasedby:

0

%andIncomeisDownby:

100

%
TheincomeofBharatImmunologicals&Biologicalsis

₹ 9cr

and

Loss

is:

₹ 4cr

BharatImmunologicals&BiologicalsLossesincreasedby:

0

%andIncomeisUpby:

900

%
By using this site you agree to the use of cookies to deliver a better site experience.